Community Health Systems, Inc.
NYSE:CYHMedical - Care Facilities
+$0.05 today
- Market cap
- $262.31M
- Beta
- 1.86
- P/E (TTM)
- -4.6
- EPS (TTM)
- -$0.66
Volume 2.88M
Average 1.61M
CYH Accounts Payables
Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.
Community Health Systems, Inc.NYSE: CYH
Accounts Payables · Q1 FY2026 · quarter ended Mar 2026
Accounts payables turns negative
Q1 FY2026 accounts payables was -$128M, compared with $103M a year earlier. Trailing-twelve-month accounts payables was -$267M. Over 3 fiscal years it compounded at -38.9% a year.
Context
- Accounts payables amounted to 0.3% of revenue in FY2025, down 0.8 pp from a year earlier.
- Accounts payables increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly accounts payables holds near -$128M or moves back toward the trailing-twelve-month quarterly average of -$66.75M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Payables history
USD · from the cash flow
- Latest · FY2025
- (36M) USD
- Year-over-year change
- -126.3%
| Period | Period end | Accounts Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (36M) | -126.3% |
| FY2024 | 2024-12-31 | 137M | +374.0% |
| FY2023 | 2023-12-31 | (50M) | +68.4% |
| FY2022 | 2022-12-31 | (158M) | -1087.5% |
| FY2021 | 2021-12-31 | 16M | — |
Accounts Payables vs competitors
How CYH compares with its peers on the latest reported figures
- Peers report in different currencies, so accounts payables is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -205.5% is the lowest of 9, against a peer median of +228.2%.
- Accounts payables amounts to 1.2% of revenue for CYH, versus a peer median of 1.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $267M USD | -205.5% | -38.9% | 1.2% | |
| LTM Mar 2026 | $40.68M USD | +418.2% | — | 4.3% | |
AUNAAuna S.A. | LTM Mar 2026 | PEN 30.65M PEN | — | — | 0.7% |
| LTM Apr 2026 | $22.9M USD | +1661.5% | -32.0% | 2.7% | |
| LTM Mar 2026 | $19.19M USD | +142.5% | — | 3.5% | |
| LTM Mar 2026 | $10.54M USD | +15832.8% | — | 11.9% | |
| LTM Mar 2026 | $4.9M USD | +151.0% | -74.3% | 0.7% | |
| LTM Mar 2026 | $1.81M USD | +305.3% | -6.6% | — | |
| LTM Mar 2026 | $1.65M USD | -163.8% | — | 0.4% | |
| LTM Mar 2026 | $1.13M USD | -76.1% | — | 0.5% | |
| Peer median (excluding CYH) | — | +228.2% | -32.0% | 1.7% | |
Competitors are the stored peer set for CYH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 230M | 46M | (133M) | (516M) | 676M |
| Depreciation & Amortization | 540M | 534M | 505M | 486M | 426M |
| Deferred Income Tax | 170M | 165M | 35M | (116M) | (243M) |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 11M |
| Change in Working Capital | (1.38B) | (479M) | (390M) | (9M) | 3M |
| Accounts Receivables | (136M) | 22M | (193M) | (66M) | 99M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 16M | (158M) | (50M) | 137M | (36M) |
| Other Working Capital | (1.26B) | (343M) | (147M) | (80M) | (60M) |
| Other Non-Cash Items | 305M | 34M | 193M | 635M | (330M) |
| Operating Cash Flow | (131M) | 300M | 210M | 480M | 543M |
| Capital Expenditures | (469M) | (415M) | (467M) | (360M) | (335M) |
| Acquisitions (Net) | 5M | 126M | 426M | 152M | 1.26B |
| Purchases of Investments | (291M) | (193M) | (213M) | (149M) | (139M) |
| Sales of Investments | 212M | 110M | 232M | 80M | 123M |
| Other Investing Activities | 0 | 121M | 0 | 0 | (62M) |
| Investing Cash Flow | (543M) | (251M) | (22M) | (277M) | 847M |
| Debt Repayment | (369M) | (305M) | (123M) | (48M) | (1B) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (5M) | (8M) | (4M) | (1M) | (2M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (121M) | (125M) | (141M) | (155M) | (165M) |
| Financing Cash Flow | (495M) | (438M) | (268M) | (204M) | (1.17B) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (1.17B) | (389M) | (80M) | (1M) | 223M |
| Free Cash Flow | (600M) | (115M) | (257M) | 120M | 208M |
Community Health Systems, Inc.
NYSE:CYH
Intrinsic Alpha fair value
Locked
Current Price
$1.86
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.